Trial: 201807045

A Phase II Study of Ruxolitinib Pre-, During- and Post-Hematopoietic Stem Cell Transplantation for Patients With Primary or Secondary Myelofibrosis

Phase

II

Principal Investigator

Schroeder, Mark

Disease Site

Bone Marrow Transplant; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov